Anti-leukemia activity of human gamma delta T cells

被引：5
|
作者：
Siegers, Gabrielle M. [1 ,2 ]
机构：
[1] Univ Western Ontario, Robarts Res Inst, Imaging Res Labs, London, ON, Canada
[2] Univ Toronto, Princess Margaret Hosp, Cell Therapy Program, Toronto, ON, Canada
来源：
ONCOIMMUNOLOGY | 2012年 / 1卷 / 02期
关键词：
gamma delta T cells; expansion protocol; preclinical investigation; in vivo bioluminescent xenograft model; adoptive cellular immunotherapy; PERIPHERAL-BLOOD; LYMPHOCYTES; LEUKEMIA;
D O I：
10.4161/onci.1.2.18231
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Two recently published articles from Siegers and colleagues detail both a novel human gamma delta T cell (GDTc) expansion protocol and a bioluminescent xenograft model of Ph+ leukemia, in which GDTc adoptive therapy was tested. Additionally, B-cell chronic lymphocytic leukemia-derived cells were newly identified as targets of preferentially expanded Vdelta1 GDTc.
引用
收藏
页码：237 / 239
页数：3
相关论文
共 50 条
  • [1] Anti-Leukemia Activity of In Vitro-Expanded Human Gamma Delta T Cells in a Xenogeneic Ph+ Leukemia Model
    Siegers, Gabrielle M.
    Felizardo, Tania C.
    Mathieson, A. Mark
    Kosaka, Yoko
    Wang, Xing-Hua
    Medin, Jeffrey A.
    Keating, Armand
    PLOS ONE, 2011, 6 (02):
  • [2] Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity
    Callahan, K. P.
    Minhajuddin, M.
    Corbett, C.
    Lagadinou, E. D.
    Rossi, R. M.
    Grose, V.
    Balys, M. M.
    Pan, L.
    Jacob, S.
    Frontier, A.
    Grever, M. R.
    Lucas, D. M.
    Kinghorn, A. D.
    Liesveld, J. L.
    Becker, M. W.
    Jordan, C. T.
    LEUKEMIA, 2014, 28 (10) : 1960 - 1968
  • [3] ANTI-LEUKEMIA ACTIVITY OF PLASMA FIBRONECTIN
    MACEWEN, EG
    HAYES, A
    MOONEY, S
    JOHN, M
    OLD, LJ
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1982, 181 (03) : 275 - 275
  • [4] Flavaglines target primitive leukemia cells and enhance anti-leukemia drug activity
    K P Callahan
    M Minhajuddin
    C Corbett
    E D Lagadinou
    R M Rossi
    V Grose
    M M Balys
    L Pan
    S Jacob
    A Frontier
    M R Grever
    D M Lucas
    A D Kinghorn
    J L Liesveld
    M W Becker
    C T Jordan
    Leukemia, 2014, 28 : 1960 - 1968
  • [5] Cytotoxic lymphocytes induced by engineered human dendritic cells mediate potent anti-leukemia activity
    Zhao, Chenchen
    Jia, Bei
    Jiang, Yixing
    Shike, Hiroko
    Annageldiyev, Charyguly
    Cioccio, Joseph
    Minagawa, Kentaro
    Mineishi, Shin
    Ehmann, Wchristopher
    Schell, Todd D.
    Cheng, Hua
    Zheng, Hong
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2025, 74 (04)
  • [6] Gamma Delta T Cells for Acute Myeloid Leukemia
    Hernandez Tejada, Fiorela Natali
    Jawed, Jawairia
    Olivares, Simon
    Mahadeo, Kris Michael
    Singh, Harjeet
    BLOOD, 2022, 140 : 12696 - 12696
  • [7] Chaetocin Exhibits Anti-Leukemia Activity Against Chronic Myeloid Leukemia Stem Cells
    Hutchinson, Catherine
    Sheridan, David P.
    DeCoteau, John F.
    Geyer, Ron
    BLOOD, 2012, 120 (21)
  • [8] Evaluating the Potential of Harnessing Anti-Leukemia T cells for Treating T-ALL
    Triplett, Todd A.
    Rios, Joshua
    Kottapalli, Srividya
    Weinberg, Andrew D.
    Somma, Alexander
    Sandoval, Trevor
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [9] Pembrolizumab Enhances the Anti-Leukemia Activity of Antigen Specific Cytotoxic T Lymphocytes
    Zhang, Mao
    Sukhumalchandra, Pariya
    Philips, Anne V.
    Qiao, Na
    Kerros, Celine
    St John, Lisa
    Perakis, Alexander A.
    Clise-Dwyer, Karen
    Mittendorf, Elizabeth
    Daver, Naval G.
    Molldrem, Jeffrey J.
    Ma, Qing
    Alatrash, Gheath
    BLOOD, 2018, 132
  • [10] Adoptive Therapy with Cord Blood Regulatory T Cells Does Not Impair Anti-Leukemia Activity of Infused Donor Cells
    Ma, Hongbing
    Nishimoto, Mitsutaka
    Zeng, Ke
    Nguyen, Tuongvan D.
    Schuler, William
    Kellner, Joshua
    Peedikayil, Jaimol
    Lyu, Mi-Ae
    Thangavelu-Devaraj, Santhana
    Parmar, Simrit
    BLOOD, 2018, 132
12345